Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplant Lymphoproliferative Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00526292
What this trial is testing

Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center 12
Early research (Phase 1)Ended earlyNCT00087009
What this trial is testing

Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00504634
What this trial is testing

Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 8
Early research (Phase 1)Study completedNCT01330173
What this trial is testing

Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma

Who this might be right for
DS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell Myeloma+1 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00003153
What this trial is testing

Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group 22
Large-scale testing (Phase 3)UnknownNCT03655145
What this trial is testing

HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyeloproliferative Syndromes+1 more
Assistance Publique - Hôpitaux de Paris 344
Testing effectiveness (Phase 2)Ended earlyNCT00450983
What this trial is testing

Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT01022996
What this trial is testing

Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.

Who this might be right for
Hodgkin Lymphoma
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)Study completedNCT00683046
What this trial is testing

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaLymphoid LeukemiaChronic Myelogenous Leukemia+6 more
University of Chicago 204
Testing effectiveness (Phase 2)Study completedNCT00627666
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Asan Medical Center 52
Testing effectiveness (Phase 2)Study completedNCT03267186
What this trial is testing

Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more
Andrew Rezvani 8
Testing effectiveness (Phase 2)UnknownNCT02753062
What this trial is testing

Bendamustine Plus Subcutaneous Rituximab in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Asan Medical Center 22
Not applicableStudy completedNCT00376922
What this trial is testing

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Wake Forest University Health Sciences 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT04904588
What this trial is testing

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMixed Phenotype Acute Leukemia+5 more
Center for International Blood and Marrow Transplant Research 300
Testing effectiveness (Phase 2)Ended earlyNCT02353468
What this trial is testing

Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
Refractory Plasma Cell Myeloma
University of Colorado, Denver 3
Large-scale testing (Phase 3)Study completedNCT01295710
What this trial is testing

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Who this might be right for
GVHDAdult Acute Myeloid LeukemiaAdult Acute Lymphoid Leukemia+1 more
Neovii Biotech 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT01318317
What this trial is testing

Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma+2 more
City of Hope Medical Center 8
Not applicableStudy completedNCT00889278
What this trial is testing

Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation

Who this might be right for
Lymphoma
Dartmouth-Hitchcock Medical Center 30
Early research (Phase 1)Study completedNCT00561418
What this trial is testing

Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Ohio State University Comprehensive Cancer Center 23
Post-approval studies (Phase 4)Looking for participantsNCT04989491
What this trial is testing

Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft

Who this might be right for
Epstein-Barr Virus Infections
University Hospital, Strasbourg, France 120
Next Page